/ / / Research & Publications
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical examiners and coroners, forensic and clinical laboratory personnel, and all other related communities about new information surrounding the emergent synthetic opioid protonitazene.
Tags: New Drug Trends Opioid Crisis Protonitazene Safety AlertN-Pyrrolidino Etonitazene has been identified in one case in May 2021. The geographical and demographical breakdown is below: Geographical...
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released its 2021 drug report this week. Using data...
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released an update on benzodiazepines this week. As of February...
The Drug Enforcement Administration’s (DEA’s) Real-Time Communication Synth-Opioids Network (Synth-Opioids) is designed to create opportunities for swift information exchange...
The NDEWS team has launched the Rapid Street Reporting (RSR) study, with the first weekend visit occurring November 12-14...
Purpose: The objective of this announcement is to notify public health and safety, clinicians, law enforcement, first responders, medical...
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913
Copyright © 2024 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy
